Correlation Between Edgewise Therapeutics and AstraZeneca PLC
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Edgewise Therapeutics and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and AstraZeneca PLC.
Diversification Opportunities for Edgewise Therapeutics and AstraZeneca PLC
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and AstraZeneca is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and AstraZeneca PLC
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 3.9 times more return on investment than AstraZeneca PLC. However, Edgewise Therapeutics is 3.9 times more volatile than AstraZeneca PLC ADR. It trades about 0.08 of its potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about 0.01 per unit of risk. If you would invest 850.00 in Edgewise Therapeutics on August 28, 2024 and sell it today you would earn a total of 2,348 from holding Edgewise Therapeutics or generate 276.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. AstraZeneca PLC ADR
Performance |
| Timeline |
| Edgewise Therapeutics |
| AstraZeneca PLC ADR |
Edgewise Therapeutics and AstraZeneca PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and AstraZeneca PLC
The main advantage of trading using opposite Edgewise Therapeutics and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| AstraZeneca PLC vs. Novartis AG ADR | AstraZeneca PLC vs. GlaxoSmithKline PLC ADR | AstraZeneca PLC vs. Roche Holding Ltd | AstraZeneca PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |